Key Drivers
- Strong Margins
- Solid Liquidity
- Intangible Risk
AIAI Summary
PBH is no longer a simple defensive cash compounder—it is now a “show-me” story where strong cash flow and decent balance-sheet resilience are offset by earnings misses, margin compression, and legal overhang, so the stock likely needs clear execution on integration, supply normalization, and margin recovery before it can re-rate.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Margins
- •Solid Liquidity
- •Intangible Risk
PBH looks fundamentally solid thanks to strong margins, cash flow, and liquidity, but its case is tempered by intangible-heavy assets, moderate capital efficiency, and limited hard-asset backing.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Failed rebound
- •Near-term resistance
Over the last month, PBH has trended sharply lower with lower highs/lows, failed rebounds in the low-50s, and now faces near-term resistance at $50-$52 and stronger resistance at $55-$56 while $46 remains tentative support.
Sharp decline from late-April highs near $58-$59, with only a modest bounce that failed to hold above the low-50s
Sentiment & News
Key News Insights:
- •Earnings miss
- •Acquisition deal
- •Legal scrutiny
Prestige Consumer Healthcare's Q4 earnings missed estimates, revenue came in soft, and a new acquisition was overshadowed by share weakness and a securities-law investigation, keeping sentiment negative.
The news is likely to weigh on PBH shares near term as weak results and regulatory concerns outweigh the strategic benefits of the acquisition
Similar Companies in Healthcare
Other companies in the same sector with AI ratings